161 related articles for article (PubMed ID: 38675462)
1. Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics.
Tang N; Ji L; Shi X; Xiong Y; Xiong X; Zhao H; Song H; Wang J; Zhang L; You S; Ji G; Liu B; Wu N
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675462
[TBL] [Abstract][Full Text] [Related]
2. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.
Dang Y; Xu J; Zhu M; Zhou W; Zhang L; Ji G
Biomed Pharmacother; 2020 Jul; 127():110127. PubMed ID: 32325349
[TBL] [Abstract][Full Text] [Related]
3. Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy.
Qiu J; Chen L; Zhang L; Xu F; Zhang C; Ren G; Chang K; He G; Du Z; Le Y; Yu Z; Li S; Liu Q; Dou X
Phytomedicine; 2023 Dec; 121():155111. PubMed ID: 37804819
[TBL] [Abstract][Full Text] [Related]
4. New aspects characterizing non-obese NAFLD by the analysis of the intestinal flora and metabolites using a mouse model.
Zhang W; Cheng W; Li J; Huang Z; Lin H; Zhang W
mSystems; 2024 Mar; 9(3):e0102723. PubMed ID: 38421203
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
[TBL] [Abstract][Full Text] [Related]
6.
Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
[TBL] [Abstract][Full Text] [Related]
7. [Intervention effect of Erchen Decoction on methionine and choline deficient diet-induced non-alcoholic steatohepatitis in mice].
Tai MT; Zhang CF; Fan CW; Tian WY; Yu Q; Fu Y; Xia DL; Mao ML; Shi DL; Ke ZL
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1310-1317. PubMed ID: 38621978
[TBL] [Abstract][Full Text] [Related]
8. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
9. [
Deng G; Jia H; Li Y; Li J; Wu C; Shi H; Qin M; Zhao J; Liu C; Liao Y; Gao L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1287-1296. PubMed ID: 37712264
[TBL] [Abstract][Full Text] [Related]
10. ZeXie decoction alleviates non-alcoholic fatty liver disease in rats: the study of genes, lipids, and gut microbiotas.
Zhang F; Wu J; Ruan H; Xia J; Xue H; Wang J; Li Q; Shi Y
Biochem Biophys Res Commun; 2022 Dec; 632():129-138. PubMed ID: 36209581
[TBL] [Abstract][Full Text] [Related]
11. Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics.
Cao YJ; Li HZ; Zhao J; Sun YM; Jin XW; Lv SQ; Luo JY; Fang XX; Wen WB; Liao JB
Evid Based Complement Alternat Med; 2022; 2022():2264394. PubMed ID: 35845577
[TBL] [Abstract][Full Text] [Related]
12. Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie-Baizhu Decoction.
Cao Y; Shi J; Song L; Xu J; Lu H; Sun J; Hou J; Chen J; Wu W; Gong L
Front Pharmacol; 2022; 13():858795. PubMed ID: 35795562
[TBL] [Abstract][Full Text] [Related]
13. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
[TBL] [Abstract][Full Text] [Related]
14. Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity.
Wu H; Lou T; Pan M; Wei Z; Yang X; Liu L; Feng M; Shi L; Qu B; Cong S; Chen K; Yang H; Liu J; Li Y; Jia Z; Xiao H
J Ethnopharmacol; 2024 May; 326():117841. PubMed ID: 38310988
[TBL] [Abstract][Full Text] [Related]
15. Untargeted metabolomics characteristics of nonobese nonalcoholic fatty liver disease induced by high-temperature-processed feed in Sprague-Dawley rats.
Xue LJ; Han JQ; Zhou YC; Peng HY; Yin TF; Li KM; Yao SK
World J Gastroenterol; 2020 Dec; 26(46):7299-7311. PubMed ID: 33362385
[TBL] [Abstract][Full Text] [Related]
16. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice.
Yang H; Wei D; Zhang Y; Jian W
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322
[TBL] [Abstract][Full Text] [Related]
17. The effects of α-lipoic acid on liver oxidative stress and free fatty acid composition in methionine-choline deficient diet-induced NAFLD.
Stanković MN; Mladenović D; Ninković M; Ethuričić I; Sobajić S; Jorgačević B; de Luka S; Vukicevic RJ; Radosavljević TS
J Med Food; 2014 Feb; 17(2):254-61. PubMed ID: 24325457
[TBL] [Abstract][Full Text] [Related]
18. [Parathyroid hormone-related protein aggravates nonalcoholic fatty liver disease induced by methionine choline-deficient diet in mice].
Qin B; Diao N; Bai L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1037-1043. PubMed ID: 34308853
[TBL] [Abstract][Full Text] [Related]
19. Erchen decoction alleviates the progression of NAFLD by inhibiting lipid accumulation and iron overload through Caveolin-1 signaling.
Deng G; Li J; Huang M; Li Y; Shi H; Wu C; Zhao J; Qin M; Liu C; Yang M; Wang Y; Zhang Y; Liao Y; Zhou C; Yang J; Xu Y; Liu B; Gao L
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117320. PubMed ID: 37838297
[TBL] [Abstract][Full Text] [Related]
20. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites.
Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W
Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
